Keyphrases
DNMT3A
100%
Melanoma
92%
Taspase1
80%
Immune Checkpoint Inhibitors
75%
Single-cell RNA Sequencing (scRNA-seq)
49%
Protease
46%
Metastatic Melanoma
44%
Overgrowth Syndrome
42%
Immune Checkpoint Blockade
40%
Hematopoietic Cells
40%
Acute Myeloid Leukemia
37%
Talimogene Laherparepvec (T-VEC)
36%
Tumor
36%
IrAE
35%
DNA Methylation (DNAm)
32%
DNA Methyltransferase 3a
32%
Mixed-phenotype Acute Leukemia
25%
Cell Proliferation
25%
T Cells
24%
Remethylation
24%
Cell Death
24%
Oncolytic Virus
24%
DNA Hypomethylation
23%
Immune Checkpoint Inhibitor Therapy
23%
Pembrolizumab
23%
Breast Cancer
23%
Cell Apoptosis
22%
Cancer Cell Proliferation
22%
Methylation
20%
Cell Characteristics
20%
Partial Correction
20%
NRAS-mutant Melanoma
20%
Immunotherapy-refractory
20%
Pemphigus Foliaceus
20%
CD4 T Cells
20%
Adjuvant Imatinib
20%
Pemphigus
20%
Bullous Pemphigoid
20%
Cancer Biology
20%
Breast Tumor
20%
Sarcoma
20%
Systematic Meta-analysis
20%
E-cadherin
20%
Human Brain
20%
Metabolic
20%
Pharmacological Inhibitors
20%
Gastrointestinal Stromal Tumor
20%
Chloroquine
20%
Gene Dysregulation
20%
Necrotic Death
20%
Biochemistry, Genetics and Molecular Biology
DNMT3A
60%
DNA Methylation
52%
Myeloid
50%
Cell Proliferation
50%
Protease
46%
Cancer Cell
40%
DNA Methyltransferase
40%
T Cell
40%
Immune Checkpoints
40%
Epigenetics
40%
Hematopoietic Cell
40%
RNA Sequence
33%
Germ Cell
26%
Germline
26%
Tumor Suppressor Protein
25%
CD4
24%
DNA Hypomethylation
23%
Methylation
21%
Proteomics
20%
Protein Catabolism
20%
Mechanistic Target of Rapamycin
20%
Histone H3
20%
Cell Cycle Progression
20%
Oncogene
20%
Protein Family
20%
Cadherin
20%
Tumor Progression
20%
T Cell Receptor
17%
Fibroblast
16%
Hematopoiesis
16%
Mouse Model
16%
Threonine
16%
Methyltransferase
15%
Gene Expression
13%
Volume
13%
Proliferating Cell Nuclear Antigen
13%
MLL2
13%
Cyclin
13%
Precursor
13%
Small Molecule
13%
Immunity
12%
Carcinogenesis
12%
Astrocyte
12%
Bisulfite Sequencing
11%
Gene Expression Profiling
10%
Arsenic Acid
10%
Anticancer
10%
Gene Deletion
10%
Arsenate
10%
Fluorescence Resonance Energy Transfer
10%
Medicine and Dentistry
Melanoma
80%
Immune Checkpoint Inhibitor
42%
Cell Death
40%
Talimogene Laherparepvec
40%
Neoplasm
38%
Metastatic Melanoma
36%
Cancer
29%
Oncolytic Virus
24%
Immunotherapy
23%
Pembrolizumab
23%
Connective Tissue Cancer
23%
Bullous Pemphigoid
20%
Arginine
20%
Neutrophil
20%
Acute Myelogenous Leukemia
20%
DNA Damage
20%
Mechanistic Target of Rapamycin
20%
RNA Sequence
20%
Necrosis
20%
Temozolomide
20%
Hyperactivation
20%
Melanosis
20%
Isoetarine
20%
Neurofibromatosis Type I
20%
Reactive Oxygen Species
20%
Small Cytoplasmic RNA
20%
Protein P53
20%
Proteomics
20%
Ipilimumab
20%
Systematic Review
20%
Chloroquine
20%
Cathepsin
20%
Meta-Analysis
20%
DNA Methyltransferase 3A
20%
Intracranial Tumor
20%
Programmed Cell Death
11%
Immune Response
10%
Skin Cancer
10%
Astrocyte
8%
Disease Exacerbation
7%
Auxotrophy
6%
Eosinophil
6%
Immune System
6%
Inflammatory Infiltrate
6%
Clear Cell Renal Cell Carcinoma
6%
T Cell
6%
Gene Mutation
6%
Cutaneous Melanoma
6%
Adverse Event
6%
Negative Feedback
6%
